The first Veracyte trade was made in Q4 2020.
Since then Paul Tudor Jones II bought shares five more times and sold shares on six occasions. The investor completely sold their stake between Q2 2023 and Q3 2023.
Avg closing price
Price range
Sold -34 Thousand shares
Q3 2023
Avg closing price
$25.72
Price range
$22.33
-
$29.92
Sold 5.1% shares (-1.83 Thousand shares)
Q2 2023
Avg closing price
$24.24
Price range
$20.96
-
$26.99
New holding (+35.8 Thousand shares)
Q1 2023
Avg closing price
$24.17
Price range
$20.58
-
$27.89
Sold -31 Thousand shares
Q4 2022
Avg closing price
$23.24
Price range
$15.31
-
$29.94
New holding (+31 Thousand shares)
Q3 2022
Avg closing price
$22.50
Price range
$16.58
-
$27.90
Sold -24.1 Thousand shares
Q2 2022
Avg closing price
$20.20
Price range
$15.45
-
$29.52
Increased shares by 22.6% (+4.45 Thousand shares)
Q1 2022
Avg closing price
$28.60
Price range
$21.94
-
$42.51
New holding (+19.6 Thousand shares)
Q4 2021
Avg closing price
$44.18
Price range
$36.09
-
$53.79
Sold -19.2 Thousand shares
Q3 2021
Avg closing price
$43.64
Price range
$35.62
-
$52.97
Increased shares by 292.0% (+14.3 Thousand shares)
Q2 2021